Other

Other Assets, Noncurrent, Fair Value Disclosure

Pfizer Other Assets, Noncurrent, Fair Value Disclosure decreased by 0.9% to $1.11B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_other_assets_noncurrent_fair_value_disclosure

Historical Data

2 periods
 Q4 '25Q1 '26
Value$1.12B$1.11B
QoQ Change—-0.9%
Range$1.11B – $1.12B

Frequently Asked Questions

What is Pfizer's other assets, noncurrent, fair value disclosure?
Pfizer (PFE) reported other assets, noncurrent, fair value disclosure of $1.11B in Q1 2026.